{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Fever, Hyperglycemia and Swallowing Management in Stroke Unit and Non-Stroke-Unit European Hospitals: A Quality in Acute Stroke Care (QASC) Europe Substudy
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Recognize the background information the authors included when presenting the results of their study determining whether the FeSS Protocols could be applied equally well in QASC Europe Study hospitals that did not have a stroke unit.
- Identify the characteristics of the participants in the authors' study of whether the FeSS Protocols could be applied equally well in QASC Europe Study hospitals that did not have a stroke unit.
- Select the results of the authors' study of whether the FeSS Protocols could be applied equally well in QASC Europe Study hospitals that did not have a stroke unit.
- Choose the conclusions the authors drew after analyzing the data they collected for their study of whether the FeSS Protocols could be applied equally well in QASC Europe Study hospitals that did not have a stroke unit.
Learning Outcomes
By the conclusion of this activity, participants will demonstrate knowledge of a study aimed at determining whether the Fever, hyperglycemia (Sugar) and Swallowing (FeSS Protocols) could be applied equally well in Quality in Acute Stroke Care (QASC) Europe Study hospitals that did not have a stroke unit by achieving a passing score on the posttest.Disclosures
All authors and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JNN0424
Published: Apr 2024
Expires: 3/6/2026
Sources:
Journal of Neuroscience Nursing
Required Passing Score: 8/10 (80%)
Categories:
Cardiovascular
,
Neurological